Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Mechanisms of Pharmacological Action”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01166763
What this trial is testing

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Who this might be right for
Breast Cancer
Carol Fabian, MD 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT06740812
What this trial is testing

Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide

Who this might be right for
Nausea and VomitingNauseaVomiting
Montefiore Medical Center 212
Post-approval studies (Phase 4)Study completedNCT01587885
What this trial is testing

Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)

Who this might be right for
Heartburn
Bayer 48
Testing effectiveness (Phase 2)Study completedNCT01754987
What this trial is testing

Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective

Who this might be right for
Metastatic Hepatocellular CarcinomaAdvanced Liver Cancer
Thomas Jefferson University 5
Early research (Phase 1)Ended earlyNCT04310592
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+17 more
Celularity Incorporated 27
Large-scale testing (Phase 3)UnknownNCT05505994
What this trial is testing

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+2 more
Daewoong Pharmaceutical Co. LTD. 340
Testing effectiveness (Phase 2)Study completedNCT03150862
What this trial is testing

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
BeiGene USA, Inc. 116
Early research (Phase 1)Study completedNCT03822065
What this trial is testing

A Relative Bioavailability Food Effect Study of LY03005

Who this might be right for
Major Depressive Disorder
Luye Pharma Group Ltd. 34
Early research (Phase 1)Study completedNCT01162486
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Johns Hopkins University 37
Large-scale testing (Phase 3)Active Not RecruitingNCT07210463
What this trial is testing

NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)

Who this might be right for
Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of Drugs+7 more
Merz Aesthetics GmbH 300
Post-approval studies (Phase 4)Study completedNCT01201811
What this trial is testing

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Celgene 44
Post-approval studies (Phase 4)Study completedNCT01828385
What this trial is testing

Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex

Who this might be right for
Neuromuscular Blockade
Universidade Federal do Rio de Janeiro 80
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Testing effectiveness (Phase 2)Study completedNCT04518852
What this trial is testing

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsDigestive System Neoplasms+5 more
Sichuan Cancer Hospital and Research Institute 27
Not applicableStudy completedNCT03904186
What this trial is testing

Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV

Who this might be right for
Human Immunodeficiency VirusSmoking CessationSmoking, Cigarette+4 more
Massachusetts General Hospital 131
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Not applicableLooking for participantsNCT06462196
What this trial is testing

Natural History of Depression, Bipolar Disorder and Suicide Risk

Who this might be right for
Behavioral SymptomsSuicideSelf-Injurious Behavior+18 more
National Institute of Mental Health (NIMH) 500
Testing effectiveness (Phase 2)Study completedNCT04722887
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Who this might be right for
Alpha1-Antitrypsin Deficiency
Grifols Therapeutics LLC 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05113251
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerHER2-positive Early Breast Cancer
AstraZeneca 927
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Next Page